The effect of acceptance and commitment therapy on fear of disease progression, anxiety sensitivity and quality of life in patients with breast cancer in stages 1, 2 and 3

Not Applicable

Conditions: Fear of disease progression in patients with breast cancer in stages 1, 2 and 3.
Malignant neoplasm of nipple and areola, right female breast
C50.011

Registration Number: IRCT20210727052000N1

Lead Sponsor: Zanjan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: Female

Target Recruitment: 80

Inclusion Criteria

Age range 18 to 50 years
No tumor metastasis
Patients who have only had 1 to 3 sessions of chemotherapy or radiotherapy
Patients must either be from Zanjan or have been staying in a guest house for at least 2 months
To have Physically ability to attend sessions
No psychosis disorders and personality disorders
Haven't been in psychotherapy during the last month
Not using psychiatric drugs
No diagnosis of misue of alcohol or addictive substances
Patients' satisfaction and interest in participating in the study

Exclusion Criteria

Patients' dissatisfaction with continuing treatment
Worsening of patients' mental or physical condition during treatment
Absence of more than one session of treatment

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Score of fear of disease progression questionnaire. Timepoint: Filling in the fear questionnaire of disease progression before the intervention, after the intervention and 3 months after the intervention. Method of measurement: Dr. Hersbach's Fear of Progress Questionnaire.;Quality of life questionnaire score for cancer patients. Timepoint: Filling out the quality of life questionnaire for cancer patients before the intervention, after the intervention, 3 months after the intervention. Method of measurement: Quality of life questionnaire for cancer patients.;Anxiety sensitivity questionnaire score. Timepoint: Filling out the anxiety sensitivity questionnaire before the intervention, after the intervention, 3 months after the intervention. Method of measurement: Anxiety Sensitivity Questionnaire.

Secondary Outcome Measures

Name	Time	Method
Scale of experimental avoidance subscale of Acceptance and Practice Questionnaire. Timepoint: Admission and practice questionnaire is completed before the intervention, after the intervention, 3 months after the intervention. Method of measurement: Bond's Admission and practice questionnaire.;Psychological flexibility (acceptance and practice questionnaire score). Timepoint: Admission and practice questionnaire is filled out before the intervention, after the intervention and 3 months after the intervention. Method of measurement: Bond's Acceptance and practice questionnaire.;Cognitive integration (Gilders Cognitive integration questionnaire score). Timepoint: The cognitive integration questionnaire is filled out before the intervention, after the intervention and 3 months after the intervention. Method of measurement: Gilders Cognitive Integration Questionnaire.